DNA, RNA, and proteins wear party hats and dance in a circle, representing a cell, under a disco ball.

Illustrated by Anthony Lewis

A mysterious cellular tango

Researchers no longer think that proteins blindly swim through the cytoplasm hoping to bump into one another. Instead, they intentionally aggregate with other biomolecules, forming membrane free, transient organelles called condensates.
Natalya Ortolano, PhD Headshot
| 2 min read

Download the infographic here

A Mysterious Cellular Tago
Illustrated by Anthony Lewis

Our understanding of how the cell functions is based on the presumption that most cellular processes occur due to the collective efforts of membrane bound organelles. Teachers often explain cell regulation by comparing it to a mail delivery system. DNA is the address and name on the envelope. The mail then moves through the “mail carrier,” or ribosome. Proteins are like mail, which gets packaged and shipped as it moves through the post office or the endoplasmic reticulum. Packaged proteins can undergo further processing in the Golgi apparatus or move into the cytoplasm to do their job. The rest was described as a defiant, anti-bureaucratic dance performed by floating proteins accidentally waltzing with the correct partner as they glided through the cytoplasm. 

Now, researchers no longer think that proteins blindly swim through the cytoplasm hoping to bump into one another. Instead, they intentionally aggregate with other biomolecules, forming membrane free, transient organelles called condensates. Scientists don’t know how cells regulate this process yet, but condensates appear to be involved in almost every cellular process (1). Now, researchers are considering how therapeutics may interact with condensates to develop effective drugs.

Finding a dance partner

All cellular molecules — RNA, DNA, proteins — seem to form transient, membrane-free condensates. Biomolecular condensates are simply local concentrations of molecules that perform similar jobs. Condensing together allows spatiotemporal control of protein-mediated cellular processes (2).

Biomolecular condensates often form via a process called biological phase separation. The gooey mix of proteins and nucleic acids separate into two phases: dense and dilute. In the dense phase, molecules with a similar job — transcription, translation, or protein turnover — condense, forming the dense phase while leaving a diluted cytoplasm and unrelated molecules in their wake.

Condensates are transient because biomolecules connect to each other in these structures through Van der waals interactions where weak, electrical forces attract molecules to one another.

Turn off the music

Researchers are trying to figure out how to concentrate drugs into condensates to ensure that the drugs effectively target the intended biological interaction or process. Our understanding of how these strange organelles are regulated is limited, however, so modifying drugs to penetrate condensates is challenging.

Many researchers at new biotech companies focused on understanding and therapeutically targeting proteins in condensates are working to modify new or existing therapeutics for cancer and Alzheimer’s disease where condensate function seems to be prevalent (3-4).

Some researchers hypothesize that cancer cells overexpress condensate-promoting proteins, allowing them to produce larger condensates. This helps cancer dodge targeted therapies that can’t penetrate the condensates to reach their targets (4).

To learn more about condensates, check out the article Biotech start-ups and condensate targeted drugs from our April 2022 issue.

References 

  1. Alberti, S. & Hyman, A. Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing. Nat Rev Mol Cell Biol  22, 196-213 (2021).
  2. Jiang, S. et al. Protein phase separation and its role in tumorigenesis. eLife e60264 (2020).
  3. Zbinden, A. et al. Phase separation and neurodegenerative diseases: A disturbance in the force. Dev Cell  55, 45-68 (2020).
  4. Boija A., et al. Biomolecular condensates and cancer. Cancer Cell  39, 174-192 (2021).

About the Author

  • Natalya Ortolano, PhD Headshot

    Natalya received her PhD in from Vanderbilt University in 2021; she joined the DDN team the same week she defended her thesis. Her work has been featured at STAT News, Vanderbilt Magazine, and Scientific American. As an assistant editor, she writes and edits online and print stories on topics ranging from cows to psychedelics. Outside of work you can probably find her at a concert in her hometown Nashville, TN.

Related Topics

Published In

April 2022 Front Cover
Volume 18 - Issue 4 | April 2022

April 2022

April 2022 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Image Alt Text	A laboratorian wearing blue gloves places a PCR sample into a real-time PCR thermocycler, the model shown is blue and white with a large digital screen.
From primer design to sample preparation, explore comprehensive strategies to optimize PCR throughput and reproducibility.
Tackling mycoplasma contamination in biotherapeutic production
DNA-based testing is emerging as a sensitive way to uncover and control a hidden threat in biomanufacturing.
Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue